BA
The Boeing Company
BA has lower modeled downside risk, despite its lower overall score.
MRCY
Mercury Systems, Inc.
MRCY has the edge over BA overall, supported by stronger modeled upside.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
MRCY Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Stable | |
| Healthy |
MRCY's balance sheet is currently healthy, and its revenue, profitability and cash flow are stable.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA's PE is 18x, but its earnings don't support one, so it isn't a reliable read right now.
MRCY PE Valuation
MRCY has no meaningful PE right now: it lost money over the past year.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect BA to return to profit, with revenue growing. However, they disagree widely on these estimates.
MRCY Forward outlook
There aren't enough analyst estimates for MRCY to show an outlook.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has the edge over MRCY on earnings quality, reporting a profit while its opponent remains loss making.
MRCY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.08 | +$0.48 |
| Q2 2026 | -$0.50 | +$0.15 |
| Q1 2026 | -$0.23 | +$0.88 |
| Q4 2025 | -$0.52 | +$1.03 |
| Q3 2025 | -$0.56 | +$1.48 |
| Q2 2025 | -$0.65 | +$1.73 |
| Q1 2025 | -$1.11 | +$1.23 |
| Q4 2024 | -$1.55 | -$0.07 |
MRCY is still losing money, but far less than before: $0.08 per share over the past year, against $2.38 at its worst in mid-2024.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA's revenue has grown year over year for seven quarters in a row: $24.2B last quarter, up 3.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA's operating margin was 1.5% last quarter, up 22 points from the same quarter a year ago.
MRCY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $253.2M | +12% |
| Q2 2026 | $289.8M | +6.1% |
| Q1 2026 | $235.8M | +12% |
| Q4 2025 | $232.9M | +4.4% |
| Q3 2025 | $225.2M | +10% |
| Q2 2025 | $273.1M | +9.9% |
| Q1 2025 | $211.4M | +1.5% |
| Q4 2024 | $223.1M | +13% |
MRCY's revenue has grown year over year for nine quarters in a row: $253M last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.3% | +11 points |
| Q2 2026 | 5% | -3.6 points |
| Q1 2026 | 2.2% | +10 points |
| Q4 2025 | -4.7% | +0.9 points |
| Q3 2025 | -3.8% | +2.7 points |
| Q2 2025 | 8.6% | +12 points |
| Q1 2025 | -8.2% | +14 points |
| Q4 2024 | -5.6% | +22 points |
MRCY has the edge over BA on profitability, with a higher operating margin.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA has the edge over MRCY on cash flow, with more consistent year-over-year improvement.
MRCY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$24.4M | -$20M |
| Q2 2026 | $28.6M | -16% |
| Q1 2026 | -$1.8M | -108% |
| Q4 2025 | $45.7M | -44% |
| Q3 2025 | -$4.4M | +$16.5M |
| Q2 2025 | $34M | -45% |
| Q1 2025 | $24.1M | +$49.8M |
| Q4 2024 | $81.9M | +118% |
MRCY usually generates cash, though not every quarter: the latest was −$24M, but it generated $48M over the past year.
BA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +2.1M shares |
| 1 year | +4.3% | +32.8M shares |
| 3 years | +31% | +186M shares |
| 5 years | +35% | +204M shares |
| Available history | +40% | +227M shares |
BA has 793M diluted shares, up 4.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
MRCY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.6% | +2.2M shares |
| 1 year | +4.1% | +2.4M shares |
| 3 years | +7.9% | +4.5M shares |
| 5 years | +11% | +6.2M shares |
| Available history | +12% | +6.6M shares |
MRCY has the edge over BA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q2 2024 | $16,000 |
| Q1 2024 | — |
| Q4 2023 | $15,000 |
| Q3 2023 | — |
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA's net debt is about 3.0 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
MRCY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.1x | Net Cash |
| Q2 2026 | -2.9x | Net Cash |
| Q1 2026 | -3.9x | Net Cash |
| Q4 2025 | -5.2x | Net Cash |
| Q3 2025 | -4.7x | Net Cash |
| Q2 2025 | -5.0x | Net Cash |
| Q1 2025 | -8.4x | Net Cash |
| Q4 2024 | -41.6x | Net Cash |
MRCY has the edge over BA on leverage, with a lower net debt burden relative to earnings.
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
MRCY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.7 | Neutral |
| Stochastic | 23.0 | Neutral |
MRCY's weekly RSI is 48 (neutral) and its Stochastic is 23 (neutral).
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA is trading at 18x earnings, a 26% discount to the Industrials sector's median of 24x, though its earnings don't support one.
MRCY PE vs Industrials Sector
| Metric | MRCY | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | — |
MRCY has no meaningful PE right now: it lost money over the past year.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
MRCY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $78.8 | 5.9% above |
| 20 week MA | $90.4 | 7.8% below |
| 50 week MA | $89.2 | 6.5% below |
| 100 week MA | $72.2 | 15% above |
| 200 week MA | $54.7 | 53% above |
MRCY has the edge over BA on trend strength, trading above more of its moving averages.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has finished lower in four of the last six years. It's down 21% so far in 2026.
MRCY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $70.3 | $86.6 | +23% |
| 2021 | $86.6 | $55.9 | -35% |
| 2022 | $55.9 | $43.5 | -22% |
| 2023 | $43.5 | $36.6 | -16% |
| 2024 | $36.6 | $41.9 | +14% |
| 2025 | $41.9 | $74.2 | +77% |
| 2026 YTD | $74.2 | $83.4 | +12% |
MRCY has the edge over BA on returns for 2026, with the stronger performance.